CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.

We recently published a list of 12 Best Fortune 500 Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

CVS faces significant 2025 headwinds, including intense pharmacy competition, threatened new federal government pressures, ...

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...

CVS Health (NYSE: CVS) is a stock that's been struggling badly for multiple years and is coming off a brutal performance in ...

CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks ...

According to Benzinga Pro, CVS Health's peer group average for short interest as a percentage of float is 9.89%, which means ...

CVS Health has disclosed plans to lay off another 13 employees who are based at or report to its offices at 151 Farmington Ave., in Hartford.

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...

Moon Capital Management, LLC, an investment management company, released its fourth quarter 2024 investor letter. A copy of ...

Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $52.00. The ...

CVS Health Corp. closed 34.84% short of its 52-week high of $80.75, which the company achieved on March 28th.